The COVID-19 Pandemic is an unprecedented disaster of humanity, affected the entire spectrum of human living. All facets of transplantation have been adversely affected, causing precipitous falls in organ donation and transplantation rates and increasing the overall mortality rates of transplant recipients in the year 2020. Despite these challenges, the COVID-19 Pandemic has revealed new opportunities in new models of care and knowledge sharing such as telemedicine, ringfencing at-risk cases, and international communities of practices to share best practices.
Professor in the Department of Medicine
University of Toronto
Atul Humar is a Professor in the Department of Medicine, University of Toronto. Dr. Humar received his medical degree from the University of Ottawa. He completed his residency and did further training in Transplant Infectious Diseases in Toronto and Boston. Dr. Humar is the Director of the Ajmera Transplant Centre at the University Health Network, and he is Director of the University of Toronto Transplant Institute. Dr. Humar’s research interests are in virology with a focus on the pathogenesis of herpesvirus infections post-transplant. He is involved in both basic and clinical research assessing immunologic and virologic determinants of infection. Dr. Humar has over 200 publications in these areas. His work was integral to the development of internationally used guidelines related to the management of infections post-transplant. He is a long-standing member of TTS and previous co-chair of the TTS Transplant ID section, and Past- President of the Canadian Society of Transplantation (CST).
Senior Consultant, Department of Renal Medicine, Singapore General Hospital
Program Director Renal Transplant Program, SingHealth-Duke NUS Transplant Centre
Dr. Terence Kee is a Senior Consultant at the Department of Renal Medicine of the Singapore General Hospital and the Program Director of the Renal Transplant Program of the SingHealth-Duke NUS Transplant Centre. He is President of the Society of Transplantation (Singapore) and Vice President of the College of Physicians at the Academy of Medicine of Singapore. Dr. Kee is an associate professor at the Duke-NUS Medical School and a Council Member of the Asian Society of Transplantation. He is a leader for transplant infrastructure projects and holds grants for novel biomarkers and anti-viral T-cell therapeutics at the Singapore General Hospital.
Deputy Executive Director Education, Training and Research
Head, Hemodialysis Unit
National Kidney and Transplant Institute
Professor of Nephrology
Kidney Foundation Hospital and Research Institute
Welcome and introduction by the Chairs
The impact of COVID 19 Pandemic on transplantation: What we should know about COVID-19?, Atul Humar, Canada
Live Q&A with Atul Humar, Canada
How to manage transplanted patients against COVID-19 in developing countries? Based on The Asian Registry Report on COVID-19, Terence Kee, Singapore
Live Q&A with Terence Kee, Singapore
Interactive panel discussion with audience participation led by the Chairs